Lodestar Investment Counsel’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | $22.3M | Sell |
76,051
-120
| -0.2% | -$35.2K | 2.29% | 15 |
|
|
2019
Q1 | $20.8M | Sell |
76,171
-1,170
| -2% | -$320K | 2.23% | 15 |
|
|
2018
Q4 | $17.3M | Buy |
77,341
+2,574
| +3% | +$576K | 2.11% | 16 |
|
|
2018
Q3 | $18.2M | Sell |
74,767
-1,464
| -2% | -$357K | 1.97% | 17 |
|
|
2018
Q2 | $15.8M | Buy |
76,231
+1,250
| +2% | +$259K | 1.82% | 18 |
|
|
2018
Q1 | $15.5M | Buy |
74,981
+810
| +1% | +$167K | 1.8% | 21 |
|
|
2017
Q4 | $14.1M | Buy |
74,171
+1,445
| +2% | +$274K | 1.62% | 21 |
|
|
2017
Q3 | $13.8M | Buy |
72,726
+1,287
| +2% | +$244K | 1.69% | 21 |
|
|
2017
Q2 | $12.5M | Buy |
71,439
+1,111
| +2% | +$194K | 1.59% | 22 |
|
|
2017
Q1 | $10.8M | Buy |
70,328
+2,955
| +4% | +$454K | 1.4% | 25 |
|
|
2016
Q4 | $9.51M | Buy |
67,373
+8,523
| +14% | +$1.2M | 1.29% | 31 |
|
|
2016
Q3 | $9.36M | Buy |
58,850
+1,740
| +3% | +$277K | 1.29% | 31 |
|
|
2016
Q2 | $8.44M | Buy |
57,110
+2,180
| +4% | +$322K | 1.2% | 36 |
|
|
2016
Q1 | $7.78M | Buy |
54,930
+5,712
| +12% | +$809K | 1.12% | 36 |
|
|
2015
Q4 | $6.98M | Buy |
49,218
+2,147
| +5% | +$305K | 1.1% | 38 |
|
|
2015
Q3 | $5.76M | Buy |
47,071
+7,215
| +18% | +$882K | 0.97% | 46 |
|
|
2015
Q2 | $5.17M | Buy |
39,856
+35,956
| +922% | +$4.67M | 0.81% | 51 |
|
|
2015
Q1 | $524K | Buy |
3,900
+900
| +30% | +$121K | 0.08% | 97 |
|
|
2014
Q4 | $376K | Hold |
3,000
| – | – | 0.11% | 88 |
|
|
2014
Q3 | $365K | Hold |
3,000
| – | – | 0.11% | 88 |
|
|
2014
Q2 | $354K | Hold |
3,000
| – | – | 0.11% | 90 |
|
|
2014
Q1 | $361K | Buy |
+3,000
| New | +$361K | 0.11% | 91 |
|